Bastide le Confort Medical SA (ENXTPA:BLC) acquired TCM Pharma on January 31, 2017. The consideration for the acquisition was paid in cash. In 2016, TCM Pharma had a turnover of €4 million. As part of the deal, Bastide will benefit from the experience of the founding manager of TCM Pharma who will continue his long-term investment in the development of his activity. TCM Pharma will be consolidated into the financial statements from January 1, 2017. Olivier Lefort et Fany Lehyaric of BZL Avocats and Arnaud Fayolle et Marie-Renée Mbock of Altana acted as legal advisors to Bastide le Confort Medical SA in the deal. Bastide le Confort Medical SA (ENXTPA:BLC) completed the acquisition of TCM Pharma on January 31, 2017.